US device market "will never stagnate"
This article was originally published in Clinica
The US medical device market will never reach stagnation because it is growing with the medical field which is constantly facing challenges, making new discoveries and developing innovative products, research analysts Frost & Sullivan said. In an upbeat teleconference presentation on February 13, called "What is hot about the US medical device industry?", research analyst Archana Swathy said that there are about 8,000 medical device companies in the US, mainly start-up companies, representing one of the "most vital and dynamic sectors" of the US economy.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.